Asia Healthcare Holdings

Overview

Asia Healthcare Holdings (AHH) is a prominent single-specialty healthcare delivery platform operating in India and South Asia. Backed by TPG Growth and GIC, AHH focuses on investing in and scaling single-specialty healthcare businesses, aiming to transform them into market leaders. The company's portfolio includes Motherhood Hospitals, Nova IVF Fertility, and the Asian Institute of Nephrology and Urology (AINU). AHH's investment strategy centers on identifying and nurturing single-specialty healthcare enterprises, providing them with the necessary capital and operational expertise to achieve sustainable growth. By focusing on specialties such as oncology, women's and children's health, fertility, urology, and nephrology, AHH addresses critical healthcare needs in the region. The company's approach has led to significant investments, including a $170 million funding from GIC in February 2022 and an additional $150 million in December 2024, totaling approximately $300 million invested across various healthcare sectors. The company's vision is to build and grow sustainable healthcare enterprises by implementing efficient management principles and expertise. AHH's goal is to transform every healthcare enterprise in Asia into a leader in its respective segment. This vision is evident in their strategic acquisitions, such as the majority stake in AINU, a specialist in urology and nephrology care, marking AHH's expansion into its fourth specialty. AHH's commitment to scaling single-specialty hospitals continues, with a focus on bridging the demand-supply gap in healthcare services across the region.

Investment Focus

• Single-specialty healthcare businesses seeking growth and operational expertise

Portfolio Companies